JUNS/ 05/20/2026 · 8:53 AM Jupiter Neurosciences Signs $100M Deal for Next-Gen MDMA Therapy Jupiter secured $100M rights to sell safer MDMA drug ALA-002 in the US, targeting mental health treatment growth.
